Mankind Pharma Limited (NSE: MANKIND)
India
· Delayed Price · Currency is INR 2,581.80
+100.20 (4.04%)
Feb 3, 2025, 3:30 PM IST
Mankind Pharma Revenue
Mankind Pharma had revenue of 32.30B INR in the quarter ending December 31, 2024, with 23.90% growth. This brings the company's revenue in the last twelve months to 116.41B, up 17.04% year-over-year. In the fiscal year ending March 31, 2024, Mankind Pharma had annual revenue of 103.35B with 18.12% growth.
Revenue (ttm)
116.41B
Revenue Growth
+17.04%
P/S Ratio
8.80
Revenue / Employee
5.96M
Employees
19,540
Market Cap
1,054.15B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 86.14B |
| Cipla | 267.20B |
| Apollo Hospitals Enterprise | 204.69B |
| Zydus Lifesciences | 214.84B |
| Aurobindo Pharma | 302.95B |
| Alkem Laboratories | 128.32B |
| Fortis Healthcare | 73.13B |